BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+9.35%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$846M
AUM Growth
+$846M
(+13%)
Cap. Flow
+$40.5M
Cap. Flow
% of AUM
4.78%
Top 10 Holdings %
Top 10 Hldgs %
28.99%
Holding
143
New
11
Increased
57
Reduced
23
Closed
11
Top Buys
| 1 |
Integra LifeSciences
IART
|
$7.92M |
| 2 |
Edwards Lifesciences
EW
|
$7.67M |
| 3 |
Cigna
CI
|
$6.73M |
| 4 |
IQVIA
IQV
|
$5.95M |
| 5 |
Labcorp
LH
|
$5.91M |
Top Sells
| 1 |
AKRX
Akorn, Inc.
AKRX
|
$11.9M |
| 2 |
Centene
CNC
|
$9.87M |
| 3 |
Incyte
INCY
|
$8M |
| 4 |
Ligand Pharmaceuticals
LGND
|
$6.69M |
| 5 |
ALR
Alere Inc
ALR
|
$5.78M |
Sector Composition
| 1 | Healthcare | 92.73% |
| 2 | Financials | 0.93% |
| 3 | Industrials | 0.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $34M | 4.02% | 261,992 +10,612 | +4% | +$1.38M |
|
2
Amgen
AMGN
$155B
| $28.2M | 3.33% | 163,728 +8,278 | +5% | +$1.43M |
|
3
Medtronic
MDT
$119B
| $27.1M | 3.21% | 305,500 +63,000 | +26% | +$5.59M |
|
4
UnitedHealth
UNH
$281B
| $23.9M | 2.83% | 129,040 +5,100 | +4% | +$946K |
|
5
Elevance Health
ELV
$71.8B
| $23.2M | 2.74% | 123,347 +12,887 | +12% | +$2.42M |
|
|
6
Edwards Lifesciences
EW
$47.8B
| $22.5M | 2.66% | 189,900 +64,900 | +52% | +$7.67M |
|
7
Intuitive Surgical
ISRG
$170B
| $22.2M | 2.62% | 23,706 +1,781 | +8% | +$1.67M |
|
8
Gilead Sciences
GILD
$140B
| $22.1M | 2.61% | 311,803 +21,375 | +7% | +$1.51M |
|
9
Abbott
ABT
$231B
| $21.5M | 2.55% | 443,000 +37,500 | +9% | +$1.82M |
|
10
Align Technology
ALGN
$10.3B
| $20.4M | 2.42% | 136,200 | – | – |
|
11
Illumina
ILMN
$15.8B
| $18.8M | 2.23% | 108,465 +9,521 | +10% | +$1.65M |
|
12
Boston Scientific
BSX
$156B
| $17.4M | 2.06% | 628,000 +56,000 | +10% | +$1.55M |
|
13
Biogen
BIIB
$19.4B
| $16.7M | 1.97% | 61,500 +8,000 | +15% | +$2.17M |
|
14
Jazz Pharmaceuticals
JAZZ
$7.75B
| $15.6M | 1.84% | 100,203 -6,397 | -6% | -$995K |
|
|
15
Incyte
INCY
$16.5B
| $15.5M | 1.84% | 123,412 -63,538 | -34% | -$8M |
|
16
Eli Lilly
LLY
$657B
| $14.9M | 1.76% | 181,073 +49,673 | +38% | +$4.09M |
|
|
WBA
17
DELISTED
Walgreens Boots Alliance
WBA
| $14.6M | 1.72% | 185,872 +25,463 | +16% | +$1.99M |
|
18
Regeneron Pharmaceuticals
REGN
$61.5B
| $13.8M | 1.63% | 28,100 -1,200 | -4% | -$589K |
|
|
19
Centene
CNC
$14.3B
| $13.6M | 1.6% | 169,810 -123,530 | -42% | -$9.87M |
|
20
Baxter International
BAX
$12.7B
| $12.5M | 1.47% | 206,000 +16,000 | +8% | +$969K |
|
21
Hologic
HOLX
$14.9B
| $12.4M | 1.47% | 273,423 -69,067 | -20% | -$3.13M |
|
22
Danaher
DHR
$147B
| $12.1M | 1.43% | 143,000 +29,000 | +25% | +$2.45M |
|
|
ABMD
23
DELISTED
Abiomed Inc
ABMD
| $12M | 1.42% | 83,970 +20,300 | +32% | +$2.91M |
|
|
24
Cigna
CI
$80.3B
| $11.9M | 1.41% | 75,500 +42,500 | +129% | +$6.73M |
|
|
BCR
25
DELISTED
CR Bard Inc.
BCR
| $11.8M | 1.39% | 37,290 -11,140 | -23% | -$3.52M |
|